declined from 63.48% to 58.46% mainly because the Company had adjusted the premium rate and condition of some non-motor policies. The overall loss ratio therefore was in decline. 2. Net investment revenue
% 4.6% -1.4% 3.9% 6.0% -2.1% Stock Gain/(Loss) & NRV -149 -425 -65% -233 -36% -382 -458 -17% Adjusted EBITDA(1) 286 653 -56% 444 -36% 730 998 -27% Adjusted EBITDA Margin (%) 6.8% 13.5% -6.7% 9.6% -2.8
discount since the demand and supply of biodiesel close to equilibrium. With deducting the effect of Stock Gain & NRV of THB 92 million, the Company had Adjusted EBITDA of THB 253 million, an increase of 18
requirements on qualifications of each type of licenses will also be adjusted accordingly to ensure that the salespersons will have proper knowledge of the products they offer. Additionally, to increase the
investment, impact investing, ESG engagement, stewardship, socially responsible investment (SRI) and sustainability investment will imply different activities for different parties. And, confusingly, sometimes
Company Limited as of 31st December 2019 as follows: A. Book value B. Adjusted book value based on market value C. Discounted cash flow method Value of shares of Modern Pharma Company Limited based on
Procedures for the Acquisition of Securities for Business Takeovers (and amended). No matter what the price of the newly issued ordinary shares is different from the market price at the date of payment of the
gains/losses wherein inventory gains decrease the cost of sales and inventory losses increase the cost of sales. Core Net Profit is the reported Net Profit less extraordinary items less tax adjusted
adjusted inventory gain/loss. Net operating debt is defined as net debt (total debt less cash and current investments) less cash outflow for the various projects underway which are not yet completed and have